Efficacy, Tolerability, and Safety Study of DFN-15
Public ClinicalTrials.gov record NCT03006276. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy, Tolerability, and Safety Study of DFN-15 in Episodic Migraine With or Without Aura
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Efficacy, Tolerability, and Safety of DFN-15 in episodic migraine with or without aura, being conducted at multiple centers in the United States.
Study identification
- NCT ID
- NCT03006276
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 622 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2016 (Type not available)
- Primary completion
- Nov 2017 (Actual)
- Completion
- May 2019 (Actual)
- Last update posted
- Jan 10, 2023
2016 – 2019
United States locations
- U.S. sites
- 45
- U.S. states
- 28
- U.S. cities
- 45
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 744 | Birmingham | Alabama | 35216 | — |
| Site 727 | Phoenix | Arizona | 85018 | — |
| Site 723 | Little Rock | Arkansas | 72211 | — |
| Site 718 | Rogers | Arkansas | 72758 | — |
| Site 709 | Los Angeles | California | 90017 | — |
| Site 708 | Orange | California | 92868 | — |
| Site 729 | San Diego | California | 92103 | — |
| Site 725 | Santa Monica | California | 90404 | — |
| Site 738 | Simi Valley | California | 93065 | — |
| Site 733 | Upland | California | 91786 | — |
| Site 726 | Colorado Springs | Colorado | 80907 | — |
| Site 735 | DeLand | Florida | 32720 | — |
| Site 711 | Hialeah | Florida | 33016 | — |
| Site 721 | Jacksonville | Florida | 32256 | — |
| Site 740 | Blue Ridge | Georgia | 30513 | — |
| Site 720 | Decatur | Georgia | 30030 | — |
| Site 734 | West Des Moines | Iowa | 50265 | — |
| Site 739 | Prairie Village | Kansas | 66208 | — |
| Site 713 | Wichita | Kansas | 67205 | — |
| Site 706 | Shreveport | Louisiana | 71105 | — |
| Site 712 | Baltimore | Maryland | 21236 | — |
| Site 703 | Boston | Massachusetts | 02131 | — |
| Site 730 | New Bedford | Massachusetts | 02740 | — |
| Site 704 | Minneapolis | Minnesota | 55402 | — |
| Site 736 | Hazelwood | Missouri | 63042 | — |
| Site 737 | Springfield | Missouri | 65807 | — |
| Site 745 | Las Vegas | Nevada | 89103 | — |
| Site 716 | Berlin | New Jersey | 08009 | — |
| Site 746 | Amherst | New York | 14226 | — |
| Site 705 | Manhattan | New York | 10018 | — |
| Site 743 | Williamsville | New York | 14221 | — |
| Site 715 | Raleigh | North Carolina | 27612 | — |
| Site 728 | Cincinnati | Ohio | 45255 | — |
| Site 707 | Dayton | Ohio | 45424 | — |
| Site 701 | Oklahoma City | Oklahoma | 73103 | — |
| Site 741 | Salem | Oregon | 97301 | — |
| Site 717 | Media | Pennsylvania | 19063 | — |
| Site 731 | Philadelphia | Pennsylvania | 19107 | — |
| Site 742 | Lincoln | Rhode Island | 02865 | — |
| Site 710 | Anderson | South Carolina | 29621 | — |
| Site 724 | Chattanooga | Tennessee | 37421 | — |
| Site 719 | Austin | Texas | 78731 | — |
| Site 702 | Plano | Texas | 75024 | — |
| Site 714 | Virginia Beach | Virginia | 23454 | — |
| Site 722 | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03006276, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 10, 2023 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03006276 live on ClinicalTrials.gov.